
Datavant
Founded Year
2017Stage
Incubator/Accelerator | AliveTotal Raised
$80.5MMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+30 points in the past 30 days
About Datavant
Datavant specializes in data connectivity and logistics for the healthcare sector. The company offers services including real-world data connectivity and data transformation to facilitate the secure and compliant movement of health information. It serves health plans, healthcare providers, life sciences, and government entities by providing solutions for improved healthcare data management. The company was founded in 2017 and is based in Phoenix, Arizona.
Loading...
ESPs containing Datavant
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The real-world data providers market offers a variety of value propositions to the pharmaceutical industry, drug labs, and healthcare organizations. It provides access to diverse patient populations, longitudinal real-world data, and patient-powered or EHR-powered controls that can replicate real-world scenarios. This can help shorten drug development timelines, reduce patient recruitment burdens …
Datavant named as Leader among 15 other companies, including IQVIA, Tempus, and Truveta.
Loading...
Research containing Datavant
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Datavant in 10 CB Insights research briefs, most recently on Jan 8, 2024.

Jan 8, 2024
4 applications of generative AI in drug R&D
Nov 10, 2023
The health insurance tech stack market map
Aug 10, 2023
The oncology tech market map
Aug 1, 2023
The clinical trials market map
May 9, 2023
7 applications of generative AI in healthcare
May 9, 2023
7 applications of generative AI in healthcareExpert Collections containing Datavant
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Datavant is included in 4 Expert Collections, including Conference Exhibitors.
Conference Exhibitors
5,302 items
Digital Health
11,305 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
Artificial Intelligence
7,221 items
Datavant Patents
Datavant has filed 10 patents.
The 3 most popular patent topics include:
- electronic health records
- health informatics
- healthcare occupations

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
9/18/2020 | 6/4/2024 | Health informatics, Electronic health records, Telehealth, Information privacy, Healthcare occupations | Grant |
Application Date | 9/18/2020 |
---|---|
Grant Date | 6/4/2024 |
Title | |
Related Topics | Health informatics, Electronic health records, Telehealth, Information privacy, Healthcare occupations |
Status | Grant |
Latest Datavant News
Mar 10, 2025
OneMedNet joins Datavant’s Real-World data ecosystem to Power Next-Gen Healthcare March 10, 2025 08:35 ET OneMedNet Corporation MINNEAPOLIS, March 10, 2025 (GLOBE NEWSWIRE) -- OneMedNet, an AI-powered Real World Data leader, has announced a collaboration with Datavant, a health data platform, to provide access to tokenized, purpose-built data for life sciences and medical research through Datavant’s health data ecosystem. Leveraging OneMedNet’s network of 31M patients, 121M+ clinical studies—EMR insights like images, ECGs, and notes—this collaboration enables life sciences companies to integrate claims data for a full view of patient journeys tailored to specific diseases. By integrating OneMedNet’s patient tokens into the Datavant ecosystem of more than 300 real-world data partners, customers seeking Real-World Data for specific patient populations can effortlessly discover and access it. This streamlined process enhances longitudinal data visibility and connectivity, enabling researchers and organizations to identify the precise insights they need to speed innovative treatments and drive impactful outcomes. “Linking healthcare data securely unlocks transformative potential for researchers,” said Aaron Green, OneMedNet CEO. “Cross-referencing our data with existing datasets through the Datavant ecosystem confirms its unique value, ensuring it’s additive, non-redundant and cost-effective. This collaboration highlights OneMedNet’s leadership in medical innovation through AI, robust platforms, and seamless integration—and will accelerate the ability of organizations to advance evidence-based solutions and access critical patient-level insights, all while safeguarding privacy.” About OneMedNet Corporation OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,400 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption. Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur. OneMedNet Contacts:
Datavant Frequently Asked Questions (FAQ)
When was Datavant founded?
Datavant was founded in 2017.
Where is Datavant's headquarters?
Datavant's headquarters is located at 2222 West Dunlap Avenue, Phoenix.
What is Datavant's latest funding round?
Datavant's latest funding round is Incubator/Accelerator.
How much did Datavant raise?
Datavant raised a total of $80.5M.
Who are the investors of Datavant?
Investors of Datavant include Plug and Play Insurtech, Roivant, Flex Capital, Johnson & Johnson Innovation, Cigna Ventures and 6 more.
Who are Datavant's competitors?
Competitors of Datavant include Aetion, Innovaccer, Tempus, Ciitizen, TriNetX and 7 more.
Loading...
Compare Datavant to Competitors

Komodo Health specializes in healthcare analytics and operates within the healthcare technology sector. The company offers a platform that provides insights by analyzing a range of healthcare data, aiming to improve patient care and reduce disease burden. Komodo Health primarily serves life sciences companies, healthcare practitioners, payers, and patient advocacy groups with its suite of software applications designed to deliver value in healthcare through data-driven insights. It was founded in 2014 and is based in San Francisco, California.

Innovaccer is a healthcare technology company that provides a platform for data activation and analytics in value-based care. The platform integrates and analyzes healthcare data for clinical, financial, operational, and experiential outcomes. Innovaccer's solutions serve providers, payers, the public sector, and life sciences. It was founded in 2014 and is based in San Francisco, California.

Evidation focuses on harnessing real-world health data to measure and improve health outcomes. The company offers a digital health measurement and engagement platform that utilizes data science and machine learning to provide health guidance, treatments, and tools. Evidation primarily serves life sciences companies, government bodies, and academic institutions. It was founded in 2012 and is based in San Mateo, California.

Owkin is an AI biotechnology company that employs artificial intelligence to improve drug discovery and development in the biopharmaceutical sector. The company specializes in AI-based identification of new treatments, clinical trial optimization, and diagnostic tool creation, while ensuring patient privacy through federated learning techniques. Owkin serves the biopharma and academic research communities. It was founded in 2016 and is based in New York, New York.
PSL Group focuses on providing research and information solutions within the healthcare industry. The company offers market research services, including testing and tracking, to assist pharmaceutical and biotechnology companies with branding strategies and marketing initiatives. PSL Group also provides online fieldwork services for conducting Internet-based market research with various types of physicians. It was founded in 2015 and is based in New York, New York.

Xevant specializes in pharmacy benefit management (PBM) analytics within the healthcare sector. The company offers a platform that provides real-time data analysis, automated reporting, and actionable insights to manage pharmacy benefits and improve health outcomes. Xevant's solutions are designed to optimize business processes, reduce costs, and enhance client satisfaction for various sectors, including PBMs, TPAs, health plans, and consultants. It was founded in 2017 and is based in Lehi, Utah.
Loading...